Pharmagen ApS: Financial statements 2016
CVR: 36687193
Source: annual report 2016, Danish Business Authority
01/10/2015 – 30/09/2016
Pharmagen ApS (CVR 36687193) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 396,649 and a net result of DKK 295,924. Equity in the 2016 report amounted to DKK 349,096. The solvency ratio was 27.6%.
- Gross Profit
- DKK 396,649
- Profit/Loss
- DKK 295,924
- Equity
- DKK 349,096
- Total Assets
- DKK 1,267,129
Official annual report
Find more companies like Pharmagen ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of September 13, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Pharmagen ApS.
About Pharmagen ApS
Pharmagen ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mads Juul Hedegaard. The company is owned by Hans-Ole Hedegaard. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -15,933 and a net result of DKK 36,023 compared with DKK -19,304 the year before. Equity in the 2025 report amounted to DKK -275,141.